HI
IDYA icon

Harbour Investments’s IDEAYA Biosciences IDYA Stock Holding History

Harbour Investments’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed – – 3129
2021
Q3 		$0 Sell
8
-3
-27% -$70 ﹤0.01% 3847
2021
Q2 		$0 Sell
11
-1
-8% -$21 ﹤0.01% 3861
2021
Q1 		$0 Buy
+12
New +$232 ﹤0.01% 3655

Other funds holding IDYA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harbour Investments's IDYA Position: Q4 2021 in Review

Harbour Investments sold out of IDEAYA Biosciences (IDYA) in Q4 2021, closing a stake of 8 shares.

Harbour Investments first reported a position in IDYA in Q1 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 110 funds tracked by Wall St. Rank hold IDYA as of Q4 2021.

  • Harbour Investments reported no remaining IDEAYA Biosciences position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 8 IDEAYA Biosciences shares in Q4 2021.
  • Harbour Investments first reported a position in IDEAYA Biosciences in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's IDEAYA Biosciences position peaked at $0 in Q3 2021.
  • 110 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.